Abstract:ObjectivesBy analyzing the different phenotypes of two Chinese DFNA9 families with the same mutation located in the intervening region between the LCCL and vWFA domains of cochlin and testing the functional changes in the mutant cochlin, we investigated the different pathogeneses for mutations in LCCL and vWFA domains.MethodsTargeted next-generation sequencing for deafness-related genes was used to identify the mutation in the proband in family #208. The probands of family #208 and family #32 with the same p.C162 Upsilon mutation were followed for more than 3 years to evaluate the progression of hearing loss and vestibular dysfunction using pure-tone audiometry, caloric testing, electrocochleogram, vestibular-evoked myogenic potential, and video head-impulse test. The disruption of normal cleavage to produce secreted LCCL domain fragments and the tendency to form aggregations of mutant cochlins were tested by in vitro cell experiments.ResultsThe two families showed different clinical symptoms. Family #32 was identified as having early-onset, progressive sensorineural hearing loss, similar to the symptoms in DFNA9 patients with cochlin mutations in the vWFA domain. The proband of family #208 endured late-onset recurrent paroxysmal vertigo attacks and progressively deteriorating hearing, similar to symptoms in those with cochlin mutations in the LCCL domain. We therefore suggest that the disrupted cleavage of the LCCL domain fragment is likely to cause vestibular dysfunction, and aggregation of mutant cochlin caused by mutations in the vWFA domain is responsible for early-onset hearing loss. The p.C162 Upsilon mutation causes either disruption of LCCL domain fragment cleavage or aggregation of mutant cochlin, resulting in the different phenotypes in the two families.ConclusionThis study demonstrates that DFNA9 families with the same genotype may have significantly different phenotypes. The mutation site in cochlin is related to the pathological mechanism underlying the different phenotypes.

Role of Protein Misfolding in DFNA9 Hearing Loss*

The role of protein misfolding in dfna 9 hearing loss

Asymmetrical Effects Of Deafness-Associated Mitochondrial Dna 7516dela Mutation On The Processing Of Rnas In The H-Strand And L-Strand Polycistronic Transcripts

Functional Characterization of the Mitochondrial 12S Rrna C1494T Mutation Associated with Aminoglycoside-Induced and Non-Syndromic Hearing Loss.

Cosegregation of the G7444A Mutation in the Mitochondrial COI/tRNASer(UCN) Genes with the 12S Rrna A1555G Mutation in a Chinese Family with Aminoglycoside‐induced and Nonsyndromic Hearing Loss

Massively Parallel Sequencing of a Chinese Family with DFNA9 Identified a Novel Missense Mutation in the LCCL Domain of COCH

Whole Exome Sequencing Identifies a Novel DFNA9 Mutation, C162Y.

Biochemical Characterization of the Mitochondrial Trnaser(ucn) T7511C Mutation Associated with Nonsyndromic Deafness

Clinical characterization of a novel COCH mutation G87V in a Chinese DFNA9 family

Different Phenotypes Of The Two Chinese Probands With The Same C.889g > A (P.C162 Upsilon) Mutation In Coch Gene Verify Different Mechanisms Underlying Autosomal Dominant Nonsyndromic Deafness 9

Amino Acid 118 in the Deafness Causing (DFNA20/26) ACTG1 Gene is a Mutational Hot Spot

Functional and Developmental Changes in the Inner Hair Cell Ribbon Synapses Caused by Myosin VI Knockout and Deafness-Inducing Point Mutation

A novel splice site mutation in DFNA5 causes late-onset progressive non-syndromic hearing loss in a Chinese family.

Sensorineural Hearing Loss and Mitochondrial Apoptosis of Cochlear Spiral Ganglion Neurons in Fibroblast Growth Factor 13 Knockout Mice

A Novel DFNA5 Mutation, IVS8+4 A>G, in the Splice Donor Site of Intron 8 Causes Late‐onset Non‐syndromic Hearing Loss in a Chinese Family

Cellular and Deafness Mechanisms Underlying Connexin Mutation-Induced Hearing Loss – A Common Hereditary Deafness

Novel OTOF Gene Mutations Identified Using a Massively Parallel DNA Sequencing Technique in DFNB9 Deafness

Molecular Basis and Restoration of Function Deficiencies of Kv7.4 Variants Associated with Inherited Hearing Loss

Identification of a novel homozygous mutation in MYO3A in a Chinese family with DFNB30 non-syndromic hearing impairment

Allele-specific antisense oligonucleotide therapy for dominantly inherited hearing impairment DFNA9

Exome Sequencing Identifies a Novel Frameshift Mutation of MYO6 as the Cause of Autosomal Dominant Nonsyndromic Hearing Loss in a Chinese Family.